NCT01224769View on ClinicalTrials.gov

Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Relapsed or Refractory Chronic Lymphoproliferative Disorders
Interventions
DRUG

bendamustine +/- rituximab

Trial Locations (1)

41124

Gruppo Italiano Studio Linfomi, Modena

All Listed Sponsors
lead

Gruppo Italiano Studio Linfomi

OTHER

NCT01224769 - Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders | Biotech Hunter | Biotech Hunter